CLINICAL, LABORATORY AND INSTRUMENTAL CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH "GROUND GLASS OPACITY" COMPUTED TOMOGRAPHIC SYMPTOM OF INTERSTITIAL LUNG DISEASE
Abstract and keywords
Abstract (English):
Rheumatoid arthritis is an inflammatory rheumatic disease with unknown etiology characterized by symmetric, chronic and erosive arthritis (synovitis) of the peripheral joints and systemic inflammatory involvement of the viscera. Lung pathology, including interstitial lung disease, is one of the common extra-articular manifestations at the гheumatoid arthritis. The leading diagnosis method of interstitial lung disease is a computed tomography high resolution, which allows to identifying interstitial lung changes in 70% of the cases. The study of prognosis in patients with rheumatoid arthritis interstitial lung disease has been the subject of several studies in the past decade. In most studies it was stated that the average life expectancy from diagnosis is around 3 years. This work is devoted to study of interstitial lung disease as one of the most frequent extra-articular ma-nifestations of rheumatoid arthritis. The authors defined the significance of computed tomography high resolu-tion for the diagnosis of pulmonary interstitial lung changes at rheumatoid arthritis. They give comparative clini-cal and immunological, instrumental characteristics of rheumatoid arthritis patients with interstitial lung disease and without it. The role of smoking and positivity of anti-cyclic citrullinated peptide (anti-CCP) according to antibodies are determined as risk factors of interstitial lung disease development in patients with rheumatoid arthritis. The interrelation of the X-ray tomography symptom of interstitial lung disease "ground glass opacity" with the activity and duration of rheumatoid arthritis is revealed. "Ground glass opacity" symptom is associated with high index of DAS28 in patients with rheumatoid arthritis with interstitial lung disease.

Keywords:
rheumatoid arthritis, interstitial lung disease, "ground glass opacity" symptom.
References

1. Nasonov E. L., Karateev D. E., Balabanova R. M. Revmatoidnyy artrit.. V kn.: Revmatologiya. Natsional´noe rukovodstvo. Pod red. E.L. Nasonova, V.A.Nasonovoy. M.: GEOTAR-Media, 2008. C. 290-331.

2. Yudin A. L., Afanas´eva N. I., Abovich Yu. A., Georgiadi S. G. Komp´yuternaya tomografiya vy-sokogo razresheniya v diagnostike interstitsial´nykh pnevmoniy.. Meditsinskaya vizualizatsiya. 2002. № 4. C. 40-48.

3. Lung abnormalities in subjects with elevations of rheumatoid arthritis-related autoantibodies without arthritis by examination and imaging suggest the lung is an early and perhaps initiating site of inflammation in rheumatoid arthritis. Ann Rheum Dis / Demoruelle M., Weisman M., Derber L. [et al.]. 2012. P. 71.

4. Jones R.S., Meade F. A theoretical and experimental analysis of anomalies in the estimation of pul-monary diffusing capacity by the single breath method. Quarterly journal of experimental physiology and cognate medical sciences. 1961. Vol. 46. P. 131-143.

5. Kim E.J., Collard H.R., King T.E. Rheumatoid arthritis-associated interstitial lung disease: the relev-ance of histopathologic and radiographic pattern. Chest. 2009. Vol. 136, №5. P. 1397-1405.

6. Epidemiological Investigation of Rheumatoid Arthritis Study Group. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope) - restricted immune reactions to autoanti-gens modified by citrullination / Klareskog L., Stolt P., Lundberg K. [et al.]. Arthritis & Rheumatology. 2006. Vol. 54. P. 38-46.

7. ATS/ERS task force. Standardization of spirometry / Miller M.R., Hankinson J., Brusasco V. [et al.]. Eur Resp J. 2005. Vol. 26, №2. P. 319-338.

8. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease / Mohd Noor N., Mohd Shahrir M.S., Shahid M.S. [et al].. Int J Rheum Dis. 2009. Vol.12. № 2. P. 136-44.

9. A gene environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis / Padyukov L., Silva C., Stolt P. [et al.]. Arthritis Rheum. 2004. Vol. 50. №10. P. 3085-3092

10. Scott D.L., Wolfe F., Huizinga T.W.J. Rheumatoid arthritis. Lancet. 2010. Vol. 376. P.1094-1108.

11. Rheumatoid arthritis-related lungs diseases: CT findings / Tanaka N., Kim J.S., Newell J.D. [et al].. Radiology. 2004. Vol. 232, №.1. P.81-91.

12. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLADRB1 shared epitope alleles / Verpoort K.N., Papendrecht-van der Voort E.A., van der Helm-van Mil A.H. [et al.]. Arthritis Rheum. 2007. Vol. 56, № 9. P. 2913-2918.

Login or Create
* Forgot password?